Product Information

ROSUVASTATIN CALCIUM 10 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0355 per EA under NDC 68462026290. Its NADAC has been published 534 times since Aug 24, 2016.

FDA first approved this application on Jul 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 10 MG TAB

Rosuvastatin calcium
$0.0355per EA

Strength

10 mg/1

NDC

68462026290

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA079172

FDA Approved

7/19/2016

TE Code

AB

On Market Since

7/19/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has been published 534 times since Aug 24, 2016, and over the history we have for it it has declined 91.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0355 per EA
All-time high$0.4109 (Oct 12, 2016)
All-time low$0.0355 (Oct 21, 2026)
52-week high$0.0400
52-week low$0.0355
Median price$0.0638
Average price$0.0883
Largest weekly change+24.4% (Aug 21, 2024)
Weeks tracked534
Tracking sinceAug 24, 2016

Price History

1W

0.0%

1M

-1.4%

3M

-6.4%

6M

-6.2%

1Y

-10.7%

3Y

-28.8%

5Y

-45.0%

All

-91.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 10 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 10 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0355 per EA (NDC 68462026290), effective Nov 11, 2026.

How has the price of ROSUVASTATIN CALCIUM 10 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has declined 91.4%. It has been tracked across 534 weekly CMS publications since Aug 24, 2016.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 10 MG TAB?

Since Aug 24, 2016, the NADAC for ROSUVASTATIN CALCIUM 10 MG TAB has ranged from a low of $0.0355 (Oct 21, 2026) to a high of $0.4109 (Oct 12, 2016), with a median of $0.0638 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 10 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 10 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 10 MG TAB?

ROSUVASTATIN CALCIUM 10 MG TAB (NDC 68462026290) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.